Mounting
evidence shows ‘cannabinoids’ in marijuana slow cancer growth, inhibit
formation of new blood cells that feed a tumor, and help manage pain,
fatigue, nausea, and other side effects. Peer-reviewed studies
in several countries ... show that THC and other marijuana-derived
compounds, known as “cannabinoids,” are effective not only for
cancer-symptom management (nausea, pain, loss of appetite, fatigue),
they also confer a direct antitumoral effect. A team of Spanish
scientists led by Manuel Guzman conducted the first clinical trial
assessing the antitumoral action of THC on human beings. THC treatment
was associated with significantly reduced tumor cell proliferation in
every test subject. Harvard University scientists reported that THC
slows tumor growth in common lung cancer and “significantly reduces the
ability of the cancer to spread.” What’s more ... THC selectively
targets and destroys tumor cells while leaving healthy cells unscathed.
Conventional chemotherapy drugs, by contrast, are highly toxic; they
indiscriminately damage the brain and body. There is mounting evidence
... that cannabinoids “represent a new class of anticancer drugs that
retard cancer growth, inhibit angiogenesis [the formation of new blood
cells that feed a tumor] and the metastatic spreading of cancer cells.” Within
the medical science community, the discovery that cannabinoids have
anti-tumoral properties is increasingly recognized as a seminal
advancement in cancer therapeutics.
Note:
Yet treatment with cannabinoids continues to be largely illegal in the
US. For an informative 15-minute documentary on the health benefits of
juicing raw cannabis, For deeply revealing reports from reliable major media sources on promising cancer-cure research,
No comments:
Post a Comment